- Home
- BRBR vs PCVX Comparison
BRBR vs PCVX Comparison
Compare BRBR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBR
- PCVX
- Stock Information
- Founded
- BRBR 2019
- PCVX 2013
- Country
- BRBR United States
- PCVX United States
- Employees
- BRBR N/A
- PCVX N/A
- Industry
- BRBR Packaged Foods
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BRBR Consumer Staples
- PCVX Health Care
- Exchange
- BRBR Nasdaq
- PCVX Nasdaq
- Market Cap
- BRBR 10.2B
- PCVX 11.5B
- IPO Year
- BRBR 2019
- PCVX 2020
- Fundamental
- Price
- BRBR $72.96
- PCVX $79.74
- Analyst Decision
- BRBR Buy
- PCVX Strong Buy
- Analyst Count
- BRBR 17
- PCVX 8
- Target Price
- BRBR $77.76
- PCVX $127.71
- AVG Volume (30 Days)
- BRBR 1.2M
- PCVX 881.2K
- Earning Date
- BRBR 02-03-2025
- PCVX 02-25-2025
- Dividend Yield
- BRBR N/A
- PCVX N/A
- EPS Growth
- BRBR 72.45
- PCVX N/A
- EPS
- BRBR 2.12
- PCVX N/A
- Revenue
- BRBR $2,098,699,999.00
- PCVX N/A
- Revenue This Year
- BRBR $17.37
- PCVX N/A
- Revenue Next Year
- BRBR $10.97
- PCVX N/A
- P/E Ratio
- BRBR $34.50
- PCVX N/A
- Revenue Growth
- BRBR 21.00
- PCVX N/A
- 52 Week Low
- BRBR $48.06
- PCVX $58.10
- 52 Week High
- BRBR $80.67
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BRBR 39.61
- PCVX 36.96
- Support Level
- BRBR $76.40
- PCVX $82.03
- Resistance Level
- BRBR $78.19
- PCVX $84.10
- Average True Range (ATR)
- BRBR 2.25
- PCVX 3.12
- MACD
- BRBR -0.41
- PCVX -0.70
- Stochastic Oscillator
- BRBR 6.77
- PCVX 1.88
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.